Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 8
Managing breast cancer in younger women: challenges and solutions
Authors Ademuyiwa F, Cyr A, Ivanovich J, Thomas M
Received 11 September 2015
Accepted for publication 6 November 2015
Published 21 December 2015 Volume 2016:8 Pages 1—12
DOI https://doi.org/10.2147/BCTT.S68848
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Tuhin Das
Peer reviewer comments 2
Editor who approved publication: Professor Pranela Rameshwar
Foluso O Ademuyiwa,1 Amy Cyr,2 Jennifer Ivanovich,2 Maria A Thomas3
1Department of Medicine, 2Department of Surgery, 3Department of Radiation Oncology, Washington University in St Louis School of Medicine, St Louis, MO, USA
Abstract: Breast cancer in young women is relatively rare compared to breast cancer occurring in older women. Younger women diagnosed with breast cancer also tend to have a more aggressive biology and consequently a poorer prognosis than older women. In addition, they face unique challenges such as diminished fertility from premature ovarian failure, extended survivorship periods and its attendant problems, and the psychosocial impact of diagnosis, while still raising families. It is therefore imperative to recognize the unique issues that younger women face, and plan management in a multidisciplinary fashion to optimize clinical outcomes. This paper discusses the challenges of breast cancer management for young women, as well as specific issues to consider in diagnosis, treatment, and follow-up of such patients.
Keywords: breast cancer, young women, diagnosis, treatment
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.